Privacy AI
Regulatory

Health data compliance, handled.

Tell us what you need. We'll tell you what it takes and how long, before you commit.

Contact us

Summary

Contact us
The regulation harmonizes regulations on a European scale, which is a major issue in terms of the health of populations across Europe on the one hand, and in terms of innovation on the other.

The regulation creates, in very concrete terms, for example:

• An infrastructure enabling the sharing of health data contained in medical records, respecting the rights of individuals, for cross-border care of people during their travels in Europe;

• An infrastructure, procedures for accessing harmonized and regulated data in member states, and catalogs of data available to facilitate the secondary reuse of health data that has been previously anonymized or pseudonymized.

The regulation strengthens and harmonizes, in addition to the GDPR, the rights of individuals concerning health data: the right of direct access to medical records, the right to object to the processing of health data, settings for access to this data, enhanced information, and facilitation of the exercise of rights for individuals, and rules for data localization.It also provides for a robust framework of European and national governance for digital health. It requires the creation, in each member state, of national authorities competent to support and control the proper application of the regulation. It strengthens European governance of digital health by replacing the eHealth network, co-chaired by France, with a committee of the EHDS with a comitology involving all stakeholders in the decisions (patients, health professionals, researchers, industrialists, institutional representatives, etc.).

The European Commission will establish the central infrastructure and services supporting the EHDS.In the medium term, the regulation also provides for the possibility of connection for countries and organizations based outside the EU, under conditions of guaranteed security and data protection.Its implementation will be spread over the next 2 to 6 years and will require adjustments to existing regulations in France, particularly concerning the reuse of health data (secondary use).

Contact us

FAQs

Our frequently questions

No items found.

Find out how iliomad can help your company.

[Map placeholder]
Only visible in production
38.709099
-39.182035
1.6
6d17042a3425c5b3
Your message has been received!
We'll get back to you as soon as possible.
Something went wrong, please try again.
Home

Discover our latest articles

View All Blog Posts
Abstract digital network connecting hospital icons, AI circuit patterns and GDPR shield symbols on a dark blue background, representing healthcare data protection themes
October 28, 2026
Healthtech
Data Breach & Cybersecurity
GDPR
Regulation
LLMS

Healthcare AI Agents, Vendor Breaches and GDPR Reforms: Weekly Privacy and Regulation Digest

This week's digest covers autonomous AI agent risks, a wave of US healthcare vendor breaches, the EU Digital Omnibus GDPR mandate and Swiss voice-biometric enforcement.

Clinical study protocol open on a desk beside a GDPR compliance checklist and a stethoscope, representing data protection obligations in clinical research
October 26, 2026
GDPR
DPIA
Health Data Strategy
Regulations & Guidelines
Regulation

Clinical study protocol data protection: a practical guide for sponsors

Learn how to embed GDPR-compliant data protection into your clinical study protocol. Practical guidance on Section 13, DPIAs, transfers and local formalities.

A researcher reviews a clinical site agreement alongside export control documentation for cross-border data transfer compliance
October 23, 2026
Regulations & Guidelines
Clinical Trials
Regulation
Consent Forms
Big Data

Clinical Site Agreement: Navigating US Export Control Review of Cross-Border Data Transfers in Clinical Trials

Learn how institutional export control policies at clinical sites affect cross-border data transfers in trials, even below DOJ Bulk Data Rule thresholds.